These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 10603368)

  • 1. Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum.
    Krishnan L; Dicaire CJ; Patel GB; Sprott GD
    Infect Immun; 2000 Jan; 68(1):54-63. PubMed ID: 10603368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfated archaeal glycolipid archaeosomes as a safe and effective vaccine adjuvant for induction of cell-mediated immunity.
    McCluskie MJ; Deschatelets L; Krishnan L
    Hum Vaccin Immunother; 2017 Dec; 13(12):2772-2779. PubMed ID: 28537465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
    Krishnan L; Sad S; Patel GB; Sprott GD
    J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfated archaeol glycolipids: Comparison with other immunological adjuvants in mice.
    Akache B; Stark FC; Jia Y; Deschatelets L; Dudani R; Harrison BA; Agbayani G; Williams D; Jamshidi MP; Krishnan L; McCluskie MJ
    PLoS One; 2018; 13(12):e0208067. PubMed ID: 30513093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methanobrevibacter smithii archaeosomes-entrapped mzNL4-3 virus-like particles induce specific T helper 1-oriented cellular and humoral responses against HIV-1.
    Salmani AS; Aghasadeghi MR; Nategh R; Mokhtari-Azad T; Siadat SD
    Curr HIV Res; 2013 Sep; 11(6):491-7. PubMed ID: 24329177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses.
    Rajananthanan P; Attard GS; Sheikh NA; Morrow WJ
    Vaccine; 1999 Feb; 17(7-8):715-30. PubMed ID: 10067677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems.
    Patel GB; Sprott GD
    Crit Rev Biotechnol; 1999; 19(4):317-57. PubMed ID: 10723627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potent adjuvant activity of archaeosomes correlates to the recruitment and activation of macrophages and dendritic cells in vivo.
    Krishnan L; Sad S; Patel GB; Sprott GD
    J Immunol; 2001 Feb; 166(3):1885-93. PubMed ID: 11160236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Archaeosomes as novel antigen delivery systems.
    Sprott GD; Tolson DL; Patel GB
    FEMS Microbiol Lett; 1997 Sep; 154(1):17-22. PubMed ID: 9297816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations.
    Jia Y; Akache B; Deschatelets L; Qian H; Dudani R; Harrison BA; Stark FC; Chandan V; Jamshidi MP; Krishnan L; McCluskie MJ
    Int J Pharm; 2019 Apr; 561():187-196. PubMed ID: 30836154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of archaeosome adjuvants evaluated in a mouse model.
    Patel GB; Omri A; Deschatelets L; Sprott GD
    J Liposome Res; 2002 Nov; 12(4):353-72. PubMed ID: 12519630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to freund's complete adjuvant, but continues to induce T helper 2 cytokine production.
    Brewer JM; Conacher M; Satoskar A; Bluethmann H; Alexander J
    Eur J Immunol; 1996 Sep; 26(9):2062-6. PubMed ID: 8814247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and biodistribution of sulfated archaeal glycolipid archaeosomes as vaccine adjuvants.
    Akache B; Stark FC; Iqbal U; Chen W; Jia Y; Krishnan L; McCluskie MJ
    Hum Vaccin Immunother; 2018 Jul; 14(7):1746-1759. PubMed ID: 29336668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Archaeosome immunostimulatory vaccine delivery system.
    Patel GB; Chen W
    Curr Drug Deliv; 2005 Oct; 2(4):407-21. PubMed ID: 16305444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic insight into the induction of cellular immune responses by encapsulated and admixed archaeosome-based vaccine formulations.
    Agbayani G; Jia Y; Akache B; Chandan V; Iqbal U; Stark FC; Deschatelets L; Lam E; Hemraz UD; Régnier S; Krishnan L; McCluskie MJ
    Hum Vaccin Immunother; 2020 Sep; 16(9):2183-2195. PubMed ID: 32755430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch.
    Ghochikyan A; Mkrtichyan M; Petrushina I; Movsesyan N; Karapetyan A; Cribbs DH; Agadjanyan MG
    Vaccine; 2006 Mar; 24(13):2275-82. PubMed ID: 16368167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired stimulation of anti-bovine serum albumin IgG antibodies by vaccine adjuvants in murine acquired immunodeficiency syndrome.
    Phillips NC
    FEMS Microbiol Immunol; 1992 Apr; 4(4):209-18. PubMed ID: 1599706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylserine receptor-mediated recognition of archaeosome adjuvant promotes endocytosis and MHC class I cross-presentation of the entrapped antigen by phagosome-to-cytosol transport and classical processing.
    Gurnani K; Kennedy J; Sad S; Sprott GD; Krishnan L
    J Immunol; 2004 Jul; 173(1):566-78. PubMed ID: 15210818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Archaeosomes as adjuvants for combination vaccines.
    Patel GB; Zhou H; KuoLee R; Chen W
    J Liposome Res; 2004; 14(3-4):191-202. PubMed ID: 15676126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OVA-bound nanoparticles induce OVA-specific IgG1, IgG2a, and IgG2b responses with low IgE synthesis.
    Yanase N; Toyota H; Hata K; Yagyu S; Seki T; Harada M; Kato Y; Mizuguchi J
    Vaccine; 2014 Oct; 32(45):5918-24. PubMed ID: 25211769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.